 | • レポートコード：MRC2-11QY08099 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は髄膜炎菌感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（MGBBP-3、NCL-195、TP-10、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別髄膜炎菌感染症治療薬の競争状況、市場シェア ・世界の髄膜炎菌感染症治療薬市場：種類別市場規模 2015年-2020年（MGBBP-3、NCL-195、TP-10、その他） ・世界の髄膜炎菌感染症治療薬市場：種類別市場規模予測 2021年-2026年（MGBBP-3、NCL-195、TP-10、その他） ・世界の髄膜炎菌感染症治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の髄膜炎菌感染症治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の髄膜炎菌感染症治療薬市場分析：米国、カナダ ・ヨーロッパの髄膜炎菌感染症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの髄膜炎菌感染症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の髄膜炎菌感染症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの髄膜炎菌感染症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Beijing Minhai Biotechnology Co Ltd、Biological E Ltd、China National Pharmaceutical Group Corp、GlaxoSmithKline Plc、Griffith University、ImmunoBiology Ltd、JN-International Medical Corp、MGB Biopharma Ltd、Panacea Biotec Ltd、Pfizer Inc、Sanofi Pasteur SA、Serum Institute of India Ltd、Wellstat Vaccines LLC ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Neisseria meningitidis Infections Drug Market
The global Neisseria meningitidis Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Neisseria meningitidis Infections Drug Scope and Market Size
Neisseria meningitidis Infections Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neisseria meningitidis Infections Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Neisseria meningitidis Infections Drug market is segmented into
MGBBP-3
NCL-195
TP-10
Others
Segment by Application, the Neisseria meningitidis Infections Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Neisseria meningitidis Infections Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Neisseria meningitidis Infections Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Neisseria meningitidis Infections Drug Market Share Analysis
Neisseria meningitidis Infections Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neisseria meningitidis Infections Drug business, the date to enter into the Neisseria meningitidis Infections Drug market, Neisseria meningitidis Infections Drug product introduction, recent developments, etc.
The major vendors covered:
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
1 Study Coverage
1.1 Neisseria meningitidis Infections Drug Product Introduction
1.2 Market Segments
1.3 Key Neisseria meningitidis Infections Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neisseria meningitidis Infections Drug Market Size Growth Rate by Type
1.4.2 MGBBP-3
1.4.3 NCL-195
1.4.4 TP-10
1.4.5 Others
1.5 Market by Application
1.5.1 Global Neisseria meningitidis Infections Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Neisseria meningitidis Infections Drug Market Size, Estimates and Forecasts
2.1.1 Global Neisseria meningitidis Infections Drug Revenue 2015-2026
2.1.2 Global Neisseria meningitidis Infections Drug Sales 2015-2026
2.2 Global Neisseria meningitidis Infections Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Neisseria meningitidis Infections Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Neisseria meningitidis Infections Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Neisseria meningitidis Infections Drug Competitor Landscape by Players
3.1 Neisseria meningitidis Infections Drug Sales by Manufacturers
3.1.1 Neisseria meningitidis Infections Drug Sales by Manufacturers (2015-2020)
3.1.2 Neisseria meningitidis Infections Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Neisseria meningitidis Infections Drug Revenue by Manufacturers
3.2.1 Neisseria meningitidis Infections Drug Revenue by Manufacturers (2015-2020)
3.2.2 Neisseria meningitidis Infections Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neisseria meningitidis Infections Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neisseria meningitidis Infections Drug Revenue in 2019
3.2.5 Global Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Neisseria meningitidis Infections Drug Price by Manufacturers
3.4 Neisseria meningitidis Infections Drug Manufacturing Base Distribution, Product Types
3.4.1 Neisseria meningitidis Infections Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neisseria meningitidis Infections Drug Product Type
3.4.3 Date of International Manufacturers Enter into Neisseria meningitidis Infections Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Neisseria meningitidis Infections Drug Market Size by Type (2015-2020)
4.1.1 Global Neisseria meningitidis Infections Drug Sales by Type (2015-2020)
4.1.2 Global Neisseria meningitidis Infections Drug Revenue by Type (2015-2020)
4.1.3 Neisseria meningitidis Infections Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neisseria meningitidis Infections Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Neisseria meningitidis Infections Drug Revenue Forecast by Type (2021-2026)
4.2.3 Neisseria meningitidis Infections Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neisseria meningitidis Infections Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Neisseria meningitidis Infections Drug Market Size by Application (2015-2020)
5.1.1 Global Neisseria meningitidis Infections Drug Sales by Application (2015-2020)
5.1.2 Global Neisseria meningitidis Infections Drug Revenue by Application (2015-2020)
5.1.3 Neisseria meningitidis Infections Drug Price by Application (2015-2020)
5.2 Neisseria meningitidis Infections Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Neisseria meningitidis Infections Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Neisseria meningitidis Infections Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Neisseria meningitidis Infections Drug by Country
6.1.1 North America Neisseria meningitidis Infections Drug Sales by Country
6.1.2 North America Neisseria meningitidis Infections Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Neisseria meningitidis Infections Drug Market Facts & Figures by Type
6.3 North America Neisseria meningitidis Infections Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Neisseria meningitidis Infections Drug by Country
7.1.1 Europe Neisseria meningitidis Infections Drug Sales by Country
7.1.2 Europe Neisseria meningitidis Infections Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neisseria meningitidis Infections Drug Market Facts & Figures by Type
7.3 Europe Neisseria meningitidis Infections Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Neisseria meningitidis Infections Drug by Region
8.1.1 Asia Pacific Neisseria meningitidis Infections Drug Sales by Region
8.1.2 Asia Pacific Neisseria meningitidis Infections Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Neisseria meningitidis Infections Drug Market Facts & Figures by Type
8.3 Asia Pacific Neisseria meningitidis Infections Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Neisseria meningitidis Infections Drug by Country
9.1.1 Latin America Neisseria meningitidis Infections Drug Sales by Country
9.1.2 Latin America Neisseria meningitidis Infections Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Neisseria meningitidis Infections Drug Market Facts & Figures by Type
9.3 Central & South America Neisseria meningitidis Infections Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Neisseria meningitidis Infections Drug by Country
10.1.1 Middle East and Africa Neisseria meningitidis Infections Drug Sales by Country
10.1.2 Middle East and Africa Neisseria meningitidis Infections Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Neisseria meningitidis Infections Drug Market Facts & Figures by Type
10.3 Middle East and Africa Neisseria meningitidis Infections Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Beijing Minhai Biotechnology Co Ltd
11.1.1 Beijing Minhai Biotechnology Co Ltd Corporation Information
11.1.2 Beijing Minhai Biotechnology Co Ltd Description and Business Overview
11.1.3 Beijing Minhai Biotechnology Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Products Offered
11.1.5 Beijing Minhai Biotechnology Co Ltd Related Developments
11.2 Biological E Ltd
11.2.1 Biological E Ltd Corporation Information
11.2.2 Biological E Ltd Description and Business Overview
11.2.3 Biological E Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biological E Ltd Neisseria meningitidis Infections Drug Products Offered
11.2.5 Biological E Ltd Related Developments
11.3 China National Pharmaceutical Group Corp
11.3.1 China National Pharmaceutical Group Corp Corporation Information
11.3.2 China National Pharmaceutical Group Corp Description and Business Overview
11.3.3 China National Pharmaceutical Group Corp Sales, Revenue and Gross Margin (2015-2020)
11.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Products Offered
11.3.5 China National Pharmaceutical Group Corp Related Developments
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Corporation Information
11.4.2 GlaxoSmithKline Plc Description and Business Overview
11.4.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Products Offered
11.4.5 GlaxoSmithKline Plc Related Developments
11.5 Griffith University
11.5.1 Griffith University Corporation Information
11.5.2 Griffith University Description and Business Overview
11.5.3 Griffith University Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Griffith University Neisseria meningitidis Infections Drug Products Offered
11.5.5 Griffith University Related Developments
11.6 ImmunoBiology Ltd
11.6.1 ImmunoBiology Ltd Corporation Information
11.6.2 ImmunoBiology Ltd Description and Business Overview
11.6.3 ImmunoBiology Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Products Offered
11.6.5 ImmunoBiology Ltd Related Developments
11.7 JN-International Medical Corp
11.7.1 JN-International Medical Corp Corporation Information
11.7.2 JN-International Medical Corp Description and Business Overview
11.7.3 JN-International Medical Corp Sales, Revenue and Gross Margin (2015-2020)
11.7.4 JN-International Medical Corp Neisseria meningitidis Infections Drug Products Offered
11.7.5 JN-International Medical Corp Related Developments
11.8 MGB Biopharma Ltd
11.8.1 MGB Biopharma Ltd Corporation Information
11.8.2 MGB Biopharma Ltd Description and Business Overview
11.8.3 MGB Biopharma Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Products Offered
11.8.5 MGB Biopharma Ltd Related Developments
11.9 Panacea Biotec Ltd
11.9.1 Panacea Biotec Ltd Corporation Information
11.9.2 Panacea Biotec Ltd Description and Business Overview
11.9.3 Panacea Biotec Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Products Offered
11.9.5 Panacea Biotec Ltd Related Developments
11.10 Pfizer Inc
11.10.1 Pfizer Inc Corporation Information
11.10.2 Pfizer Inc Description and Business Overview
11.10.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Inc Neisseria meningitidis Infections Drug Products Offered
11.10.5 Pfizer Inc Related Developments
11.1 Beijing Minhai Biotechnology Co Ltd
11.1.1 Beijing Minhai Biotechnology Co Ltd Corporation Information
11.1.2 Beijing Minhai Biotechnology Co Ltd Description and Business Overview
11.1.3 Beijing Minhai Biotechnology Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Products Offered
11.1.5 Beijing Minhai Biotechnology Co Ltd Related Developments
11.12 Serum Institute of India Ltd
11.12.1 Serum Institute of India Ltd Corporation Information
11.12.2 Serum Institute of India Ltd Description and Business Overview
11.12.3 Serum Institute of India Ltd Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Serum Institute of India Ltd Products Offered
11.12.5 Serum Institute of India Ltd Related Developments
11.13 Wellstat Vaccines LLC
11.13.1 Wellstat Vaccines LLC Corporation Information
11.13.2 Wellstat Vaccines LLC Description and Business Overview
11.13.3 Wellstat Vaccines LLC Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Wellstat Vaccines LLC Products Offered
11.13.5 Wellstat Vaccines LLC Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Neisseria meningitidis Infections Drug Market Estimates and Projections by Region
12.1.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Neisseria meningitidis Infections Drug Revenue Forecast by Regions 2021-2026
12.2 North America Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.2.1 North America: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.2.2 North America: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.2.3 North America: Neisseria meningitidis Infections Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.3.2 Europe: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Neisseria meningitidis Infections Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Neisseria meningitidis Infections Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Neisseria meningitidis Infections Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Neisseria meningitidis Infections Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Neisseria meningitidis Infections Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Neisseria meningitidis Infections Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Neisseria meningitidis Infections Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Neisseria meningitidis Infections Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neisseria meningitidis Infections Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Neisseria meningitidis Infections Drug Market Segments
Table 2. Ranking of Global Top Neisseria meningitidis Infections Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neisseria meningitidis Infections Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of MGBBP-3
Table 5. Major Manufacturers of NCL-195
Table 6. Major Manufacturers of TP-10
Table 7. Major Manufacturers of Others
Table 8. Global Neisseria meningitidis Infections Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Neisseria meningitidis Infections Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Neisseria meningitidis Infections Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Neisseria meningitidis Infections Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Neisseria meningitidis Infections Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Neisseria meningitidis Infections Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Neisseria meningitidis Infections Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Neisseria meningitidis Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Neisseria meningitidis Infections Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neisseria meningitidis Infections Drug as of 2019)
Table 17. Neisseria meningitidis Infections Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Neisseria meningitidis Infections Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Neisseria meningitidis Infections Drug Price (2015-2020) (USD/Pcs)
Table 20. Neisseria meningitidis Infections Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Neisseria meningitidis Infections Drug Product Type
Table 22. Date of International Manufacturers Enter into Neisseria meningitidis Infections Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Neisseria meningitidis Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 25. Global Neisseria meningitidis Infections Drug Sales Share by Type (2015-2020)
Table 26. Global Neisseria meningitidis Infections Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Neisseria meningitidis Infections Drug Revenue Share by Type (2015-2020)
Table 28. Neisseria meningitidis Infections Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Neisseria meningitidis Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 30. Global Neisseria meningitidis Infections Drug Sales Share by Application (2015-2020)
Table 31. North America Neisseria meningitidis Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 32. North America Neisseria meningitidis Infections Drug Sales Market Share by Country (2015-2020)
Table 33. North America Neisseria meningitidis Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Neisseria meningitidis Infections Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Neisseria meningitidis Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 36. North America Neisseria meningitidis Infections Drug Sales Market Share by Type (2015-2020)
Table 37. North America Neisseria meningitidis Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 38. North America Neisseria meningitidis Infections Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Neisseria meningitidis Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Neisseria meningitidis Infections Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Neisseria meningitidis Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Neisseria meningitidis Infections Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Neisseria meningitidis Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Neisseria meningitidis Infections Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Neisseria meningitidis Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Neisseria meningitidis Infections Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Neisseria meningitidis Infections Drug Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Neisseria meningitidis Infections Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Neisseria meningitidis Infections Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Neisseria meningitidis Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Neisseria meningitidis Infections Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Neisseria meningitidis Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Neisseria meningitidis Infections Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Neisseria meningitidis Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Neisseria meningitidis Infections Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Neisseria meningitidis Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Neisseria meningitidis Infections Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Neisseria meningitidis Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Neisseria meningitidis Infections Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Neisseria meningitidis Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Neisseria meningitidis Infections Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Neisseria meningitidis Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Neisseria meningitidis Infections Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Neisseria meningitidis Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share by Application (2015-2020)
Table 71. Beijing Minhai Biotechnology Co Ltd Corporation Information
Table 72. Beijing Minhai Biotechnology Co Ltd Description and Major Businesses
Table 73. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Beijing Minhai Biotechnology Co Ltd Product
Table 75. Beijing Minhai Biotechnology Co Ltd Recent Development
Table 76. Biological E Ltd Corporation Information
Table 77. Biological E Ltd Description and Major Businesses
Table 78. Biological E Ltd Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Biological E Ltd Product
Table 80. Biological E Ltd Recent Development
Table 81. China National Pharmaceutical Group Corp Corporation Information
Table 82. China National Pharmaceutical Group Corp Description and Major Businesses
Table 83. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. China National Pharmaceutical Group Corp Product
Table 85. China National Pharmaceutical Group Corp Recent Development
Table 86. GlaxoSmithKline Plc Corporation Information
Table 87. GlaxoSmithKline Plc Description and Major Businesses
Table 88. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. GlaxoSmithKline Plc Product
Table 90. GlaxoSmithKline Plc Recent Development
Table 91. Griffith University Corporation Information
Table 92. Griffith University Description and Major Businesses
Table 93. Griffith University Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Griffith University Product
Table 95. Griffith University Recent Development
Table 96. ImmunoBiology Ltd Corporation Information
Table 97. ImmunoBiology Ltd Description and Major Businesses
Table 98. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. ImmunoBiology Ltd Product
Table 100. ImmunoBiology Ltd Recent Development
Table 101. JN-International Medical Corp Corporation Information
Table 102. JN-International Medical Corp Description and Major Businesses
Table 103. JN-International Medical Corp Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. JN-International Medical Corp Product
Table 105. JN-International Medical Corp Recent Development
Table 106. MGB Biopharma Ltd Corporation Information
Table 107. MGB Biopharma Ltd Description and Major Businesses
Table 108. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. MGB Biopharma Ltd Product
Table 110. MGB Biopharma Ltd Recent Development
Table 111. Panacea Biotec Ltd Corporation Information
Table 112. Panacea Biotec Ltd Description and Major Businesses
Table 113. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Panacea Biotec Ltd Product
Table 115. Panacea Biotec Ltd Recent Development
Table 116. Pfizer Inc Corporation Information
Table 117. Pfizer Inc Description and Major Businesses
Table 118. Pfizer Inc Neisseria meningitidis Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Pfizer Inc Product
Table 120. Pfizer Inc Recent Development
Table 121. Sanofi Pasteur SA Corporation Information
Table 122. Sanofi Pasteur SA Description and Major Businesses
Table 123. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Sanofi Pasteur SA Product
Table 125. Sanofi Pasteur SA Recent Development
Table 126. Serum Institute of India Ltd Corporation Information
Table 127. Serum Institute of India Ltd Description and Major Businesses
Table 128. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 129. Serum Institute of India Ltd Product
Table 130. Serum Institute of India Ltd Recent Development
Table 131. Wellstat Vaccines LLC Corporation Information
Table 132. Wellstat Vaccines LLC Description and Major Businesses
Table 133. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 134. Wellstat Vaccines LLC Product
Table 135. Wellstat Vaccines LLC Recent Development
Table 136. Global Neisseria meningitidis Infections Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 137. Global Neisseria meningitidis Infections Drug Sales Market Share Forecast by Regions (2021-2026)
Table 138. Global Neisseria meningitidis Infections Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 139. Global Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 140. North America: Neisseria meningitidis Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 141. North America: Neisseria meningitidis Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Europe: Neisseria meningitidis Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 143. Europe: Neisseria meningitidis Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Asia Pacific: Neisseria meningitidis Infections Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 145. Asia Pacific: Neisseria meningitidis Infections Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 146. Latin America: Neisseria meningitidis Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. Latin America: Neisseria meningitidis Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Middle East and Africa: Neisseria meningitidis Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 149. Middle East and Africa: Neisseria meningitidis Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 151. Key Challenges
Table 152. Market Risks
Table 153. Main Points Interviewed from Key Neisseria meningitidis Infections Drug Players
Table 154. Neisseria meningitidis Infections Drug Customers List
Table 155. Neisseria meningitidis Infections Drug Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Neisseria meningitidis Infections Drug Product Picture
Figure 2. Global Neisseria meningitidis Infections Drug Sales Market Share by Type in 2020 & 2026
Figure 3. MGBBP-3 Product Picture
Figure 4. NCL-195 Product Picture
Figure 5. TP-10 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Neisseria meningitidis Infections Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Neisseria meningitidis Infections Drug Report Years Considered
Figure 12. Global Neisseria meningitidis Infections Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Neisseria meningitidis Infections Drug Sales 2015-2026 (K Pcs)
Figure 14. Global Neisseria meningitidis Infections Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Neisseria meningitidis Infections Drug Sales Market Share by Region in 2019
Figure 17. Global Neisseria meningitidis Infections Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Neisseria meningitidis Infections Drug Revenue Market Share by Region in 2019
Figure 19. Global Neisseria meningitidis Infections Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Neisseria meningitidis Infections Drug Revenue in 2019
Figure 21. Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Neisseria meningitidis Infections Drug Sales Market Share by Type in 2019
Figure 24. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type in 2019
Figure 26. Global Neisseria meningitidis Infections Drug Market Share by Price Range (2015-2020)
Figure 27. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Neisseria meningitidis Infections Drug Sales Market Share by Application in 2019
Figure 29. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application in 2019
Figure 31. North America Neisseria meningitidis Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Neisseria meningitidis Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Neisseria meningitidis Infections Drug Sales Market Share by Country in 2019
Figure 34. North America Neisseria meningitidis Infections Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Neisseria meningitidis Infections Drug Market Share by Type in 2019
Figure 40. North America Neisseria meningitidis Infections Drug Market Share by Application in 2019
Figure 41. Europe Neisseria meningitidis Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Neisseria meningitidis Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Neisseria meningitidis Infections Drug Sales Market Share by Country in 2019
Figure 44. Europe Neisseria meningitidis Infections Drug Revenue Market Share by Country in 2019
Figure 45. Germany Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Neisseria meningitidis Infections Drug Market Share by Type in 2019
Figure 56. Europe Neisseria meningitidis Infections Drug Market Share by Application in 2019
Figure 57. Asia Pacific Neisseria meningitidis Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Neisseria meningitidis Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Neisseria meningitidis Infections Drug Revenue Market Share by Region in 2019
Figure 61. China Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Neisseria meningitidis Infections Drug Market Share by Type in 2019
Figure 84. Asia Pacific Neisseria meningitidis Infections Drug Market Share by Application in 2019
Figure 85. Latin America Neisseria meningitidis Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Neisseria meningitidis Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Neisseria meningitidis Infections Drug Sales Market Share by Country in 2019
Figure 88. Latin America Neisseria meningitidis Infections Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Neisseria meningitidis Infections Drug Market Share by Type in 2019
Figure 96. Latin America Neisseria meningitidis Infections Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Neisseria meningitidis Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Neisseria meningitidis Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Neisseria meningitidis Infections Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Neisseria meningitidis Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Neisseria meningitidis Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Neisseria meningitidis Infections Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Neisseria meningitidis Infections Drug Market Share by Application in 2019
Figure 109. North America Neisseria meningitidis Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Neisseria meningitidis Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Neisseria meningitidis Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Neisseria meningitidis Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Neisseria meningitidis Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Neisseria meningitidis Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Neisseria meningitidis Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Neisseria meningitidis Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Neisseria meningitidis Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Neisseria meningitidis Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
ナイセリア淋菌感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Neisseria Gonorrhoeae Infections Treatment Market The global Neisseria Gonorrhoeae Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Neisseria Gonorrhoeae Infecti…- 類鼻疽菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Burkholderia Pseudomallei Infections Drug Market The global Burkholderia Pseudomallei Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Burkholderia Pseudomallei Infec…
- ライノウイルス感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Rhinovirus Infections Drug Market The global Rhinovirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rhinovirus Infections Drug Scope and Market Size Rhinovirus I…
- ロタウイルス感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Rotavirus Infections Drug Market The global Rotavirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rotavirus Infections Drug Scope and Market Size Rotavirus Infec…
- A型インフルエンザウイルス・H3N2亜型感染症薬の世界市場（～2026年） Market Analysis and Insights: Global Influenza A Virus, H3N2 Subtype Infections Drug Market The global Influenza A Virus, H3N2 Subtype Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Influenza A Virus, …